Symptom burden may increase hospital length of stay, readmission risk in advanced cancer

"Hospitalized patients with advanced cancer experience an immense burden of physical and psychological symptoms," says Ryan Nipp MD, of the MGH Cancer Center, co-lead and corresponding author of the Cancer paper. "Patients' symptoms represent potentially modifiable risk factors, and prior research has shown that interventions aimed at symptom improvement can enhance patient-reported outcomes. We found novel results regarding the relationship between patients' symptoms and their use of health care services, which highlight the critical need to develop and test interventions addressing the symptoms experienced by hospitalized patients with advanced cancer to improve both the care these patients receive and their utilization of health care services."

The study enrolled 1,036 patients with advanced cancer -- defined as those receiving treatment focused on comfort or symptom relief, rather than an attempt to cure their disease -- with unplanned admissions to the MGH from September 2104 through May 2016. Upon admission, participants completed several surveys designed to assess the presence of physical symptoms -- such as pain, fatigue, drowsiness, nausea, poor appetite and shortness of breath -- and symptoms of depression and anxiety.

More than half of the participating patients reported currently experiencing moderate to severe fatigue, pain, drowsiness, lack of appetite or poor overall well-being. More than a quarter reported significant levels of depression or anxiety symptoms. Patients' physical symptoms were significantly associated with longer hospital lengths of stay and increased risk of unplanned readmission within 90 days. Overall psychological distress and depression scores were associated with longer lengths of stay, while patients' anxiety symptoms were associated with higher readmission risk.

"We know that hospitalized patients with advanced cancer often experience a higher symptom burden compared with those treated in the outpatient setting, but until now, most efforts to improve symptom management have focused on ambulatory patients," says Nipp, who is an instructor in Medicine at Harvard Medical School. "There is a critical need to focus on efforts to alleviate suffering among hospitalized patients with advanced cancer. For example, future efforts should determine the efficacy of implementing symptom monitoring and supportive care interventions for such patients in an effort to relieve their symptoms, improve quality of life and enhance the quality of their cancer care."